KALA BIO, INC. Fair Value Adjustment of Warrants
KALA BIO, INC. (KALA) reported Fair Value Adjustment of Warrants of $1.84 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2019-03-12
- KALA BIO, INC. fair value adjustment of warrants for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- KALA BIO, INC. fair value adjustment of warrants for the quarter ending 2017-09-30 was $623.00K.
- KALA BIO, INC. fair value adjustment of warrants for the quarter ending 2017-06-30 was $1.19M, a 2421.28% increase year-over-year.
- KALA BIO, INC. fair value adjustment of warrants for the quarter ending 2017-03-31 was $36.00K.
- KALA BIO, INC. fair value adjustment of warrants for fiscal 2017 was $1.84M.
- KALA BIO, INC. fair value adjustment of warrants for fiscal 2016 was -$122.00K, a 192.42% decline from fiscal 2015.
- KALA BIO, INC. fair value adjustment of warrants for fiscal 2015 was $132.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $623.00K derived: sum of 2 quarters · filed 2019-03-12 | $1.81M derived: sum of 3 quarters · filed 2019-03-12 | $1.84M 10-K · filed 2019-03-12 |
| 2017-09-30 | $623.00K 10-Q · filed 2018-11-08 | $1.81M derived: sum of 2 quarters · filed 2018-11-08 | $1.84M 10-Q · filed 2018-11-08 | $1.90M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $1.19M 10-Q · filed 2018-08-09 | $1.22M 10-Q · filed 2018-08-09 | $1.28M derived: sum of 3 quarters · filed 2018-08-09 | $1.07M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $36.00K 10-Q · filed 2018-05-10 | $91.00K derived: sum of 2 quarters · filed 2018-05-10 | -$115.00K derived: sum of 3 quarters · filed 2018-05-10 | -$68.00K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$151.00K derived: sum of 2 quarters · filed 2018-04-02 | -$104.00K derived: sum of 3 quarters · filed 2018-04-02 | -$122.00K 10-K · filed 2018-04-02 |
| 2016-09-30 | -$206.00K 10-Q · filed 2017-11-07 | -$159.00K derived: sum of 2 quarters · filed 2017-11-07 | -$177.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $47.00K 10-Q · filed 2017-08-31 | $29.00K 10-Q · filed 2017-08-31 | ||
| 2015-12-31 | $132.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |